nicorandil
2024-2375
Approved small_molecule active
Quick answer
nicorandil for STEMI - ST-segment Elevation Myocardial Infarction is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- STEMI - ST-segment Elevation Myocardial Infarction
- Phase
- Approved
- Modality
- small_molecule
- Status
- active